[go: up one dir, main page]

BR0208508A - Cyclopropylindole derivatives as selective serotonin uptake inhibitors - Google Patents

Cyclopropylindole derivatives as selective serotonin uptake inhibitors

Info

Publication number
BR0208508A
BR0208508A BR0208508-9A BR0208508A BR0208508A BR 0208508 A BR0208508 A BR 0208508A BR 0208508 A BR0208508 A BR 0208508A BR 0208508 A BR0208508 A BR 0208508A
Authority
BR
Brazil
Prior art keywords
disorders
derivatives
selective serotonin
cyclopropylindole
uptake inhibitors
Prior art date
Application number
BR0208508-9A
Other languages
Portuguese (pt)
Inventor
Ronald Mattson
Derek Denhart
Jeffrey DESKUS
Jonathan Ditta
Lawrence MARCIN
James Epperson
John Catt
Dalton King
Mendi Higgins
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority claimed from PCT/US2002/006627 external-priority patent/WO2002079152A1/en
Publication of BR0208508A publication Critical patent/BR0208508A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DERIVADOS DE CICLOPROPILINDOL COMO INIBIDORES SELETIVOS DA CAPTAçãO DE SEROTONINA. A presente invenção está relacionada aos compostos de fórmula (I) e seus sais ou solvatos farmaceuticamente aceitáveis e formulações farmaceuticamente aceitáveis que compreendem os citados composoto úteis para o tratamento da depressão, de distúrbios da ansiedade, ejaculação precoce, dor crónica, distúrbios compulsivo-obssessivo, distúrbios alimentares, distúrbios pré-mestrual disfórico, distúrbios do pânico e distúrbios psicóticos incluindo distúrbios bipolares e esquizofrenia.CYCLOPROPILINDOL DERIVATIVES AS SELECTIVE SEROTONIN-INHIBITORS. The present invention relates to the compounds of formula (I) and their pharmaceutically acceptable salts or solvates and pharmaceutically acceptable formulations comprising said compounds useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive compulsive disorders , eating disorders, dysphoric premenstrual disorders, panic disorders and psychotic disorders including bipolar disorders and schizophrenia.

BR0208508-9A 2001-03-29 2002-03-05 Cyclopropylindole derivatives as selective serotonin uptake inhibitors BR0208508A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27988801P 2001-03-29 2001-03-29
US29312201P 2001-05-23 2001-05-23
US23780401P 2001-10-09 2001-10-09
PCT/US2002/006627 WO2002079152A1 (en) 2001-03-29 2002-03-05 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
BR0208508A true BR0208508A (en) 2004-04-20

Family

ID=32234124

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208508-9A BR0208508A (en) 2001-03-29 2002-03-05 Cyclopropylindole derivatives as selective serotonin uptake inhibitors

Country Status (1)

Country Link
BR (1) BR0208508A (en)

Similar Documents

Publication Publication Date Title
BRPI0510515A (en) morpholine compounds
BR0312729A (en) New indole-3-sulfur derivatives
BR0312232A (en) Caspase inhibitors and their uses
BRPI0407976A (en) 2,5 and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
SV2002000504A (en) REPLACED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH REF.PC10760 / 20205 / BB
BR0207526A (en) Compound, pharmaceutical composition, and methods for treating pain, migraine, depression, anxiety, schizophrenia, parkinson's disease, or stroke
BR0112756A (en) Compound, pharmaceutical composition, methods for treating prostaglandin-mediated diseases, nasal congestion, allergic asthma, and allergic rhinitis, and use of a compound
GT200400116A (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES.
BRPI0607017B8 (en) pharmaceutical composition comprising memantine and donezepil, and their use for the treatment of snc-related conditions
AR047529A1 (en) SUBSTITUTED QUINOLINE COMPOUNDS
BRPI0408990A (en) pyrimidin-4-one derivatives and their use as p38 kinase modulators
PE20070541A1 (en) COMPOUNDS AND COMPOSITIONS INCLUDING ISOINDOL-IMIDES
ECSP034732A (en) DERIVATIVE OF PHENETHANOLAMINE FOR THE TREATMENT OF RESPIRATORY DISEASES
BRPI0413555A (en) compound or salt thereof, pharmaceutical composition, use of a compound or salt, and method for treating a disease, for the manufacture of a compound and for the preparation of compound
BRPI0513717A (en) pyridine derivatives
BRPI0415683A (en) norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
BRPI0510453A (en) Substituted Morpholine Compounds for the Treatment of Central Nervous System Disorders
UY30377A1 (en) FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA
BRPI0417520A (en) Substituted 1h-pyrrolo [3,2-b, 3,2-c, and 2,3-c] pyridine-2-carboxamides and analogues reported as inhibitors of i-epsilon casein kinase
UY26924A1 (en) PHENOXIBENCILAMINE DERIVATIVES AS SSRI
BRPI0508051A (en) heteroarylaminopyrazole derivatives usable for the treatment of diabetes
BRPI0417714A (en) compound, pharmaceutical composition, and use of a compound
CO5611124A2 (en) BENZOFURAN DERIVATIVES SUBSTITUTED USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS
BR0308133A (en) Crystalline polymorphic form of irinotecan hydrochloride
BRPI0415826A (en) keto-oxadiazole derivatives as cathepsin inhibitors

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]